These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6459256

  • 1. Tizanidine (DS 103-282) in the treatment of acute paravertebral muscle spasm: a controlled trial comparing tizanidine and diazepam.
    Fryda-Kaurimsky Z, Müller-Fassbender H.
    J Int Med Res; 1981; 9(6):501-5. PubMed ID: 6459256
    [Abstract] [Full Text] [Related]

  • 2. A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin.
    Hennies OL.
    J Int Med Res; 1981; 9(1):62-8. PubMed ID: 6451461
    [Abstract] [Full Text] [Related]

  • 3. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia.
    Bes A, Eyssette M, Pierrot-Deseilligny E, Rohmer F, Warter JM.
    Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129
    [Abstract] [Full Text] [Related]

  • 4. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L, Shellenberger MK, Davis CS.
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [Abstract] [Full Text] [Related]

  • 5. Effects of tizanidine in healthy volunteers: double-blind study compared with diazepam and a placebo.
    Yanagita T, Yamamura H, Igarashi S.
    Int J Clin Pharmacol Res; 1988; 8(2):75-94. PubMed ID: 3378856
    [Abstract] [Full Text] [Related]

  • 6. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain.
    Berry H, Hutchinson DR.
    J Int Med Res; 1988; 16(2):75-82. PubMed ID: 2967780
    [Abstract] [Full Text] [Related]

  • 7. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C, Muff S, Smolenski-Kautz S.
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [Abstract] [Full Text] [Related]

  • 8. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
    Wallace JD.
    Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
    [Abstract] [Full Text] [Related]

  • 9. The spasmolytic properties of 5-chloro-4-(2-imidazolin-2-yl-amino)-2, 1,3-benzothiadiazole hydrochloride (DS 103-282): a pilot study.
    Sie OG, Lakke JP.
    Clin Neurol Neurosurg; 1980 Nov; 82(4):273-9. PubMed ID: 6263533
    [Abstract] [Full Text] [Related]

  • 10. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice.
    Berry H, Hutchinson DR.
    J Int Med Res; 1988 Nov; 16(2):83-91. PubMed ID: 2967781
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.
    Soonawalla DF, Joshi N.
    J Indian Med Assoc; 2008 May; 106(5):331-5. PubMed ID: 18839644
    [Abstract] [Full Text] [Related]

  • 13. Tizanidine for the management of acute postoperative pain after inguinal hernia repair: A placebo-controlled double-blind trial.
    Yazicioğlu D, Caparlar C, Akkaya T, Mercan U, Kulaçoğlu H.
    Eur J Anaesthesiol; 2016 Mar; 33(3):215-22. PubMed ID: 26555871
    [Abstract] [Full Text] [Related]

  • 14. Comparative profile of tizanidine in the management of spasticity.
    Lataste X, Emre M, Davis C, Groves L.
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [Abstract] [Full Text] [Related]

  • 15. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.
    Wagstaff AJ, Bryson HM.
    Drugs; 1997 Mar; 53(3):435-52. PubMed ID: 9074844
    [Abstract] [Full Text] [Related]

  • 16. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L, Henney HR, Runyan JD.
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [Abstract] [Full Text] [Related]

  • 17. Tizanidine in the treatment of spasticity.
    Newman PM, Nogues M, Newman PK, Weightman D, Hudgson P.
    Eur J Clin Pharmacol; 1982 Feb; 23(1):31-5. PubMed ID: 6751834
    [Abstract] [Full Text] [Related]

  • 18. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM, Guin-Renfroe S, Johnson A, Brunner RM.
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [Abstract] [Full Text] [Related]

  • 19. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD.
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [Abstract] [Full Text] [Related]

  • 20. Clinically Significant Bradycardia From Tizanidine.
    Masood U, Kahlon A, Mousa O.
    Am J Ther; 2018 Nov; 25(3):e385-e386. PubMed ID: 28177941
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.